SHARON, Pa., June 19 /PRNewswire-FirstCall/ -- NanoLogix, Inc. , a nanobiotechnology company engaged in the research, development and commercialization of hydrogen bioreactors announced today that it has filed six patent applications for greatly improving the efficacy for hydrogen production of hydrogen bioreactors. The patent applications concern improvements in both the methodology and apparatus involving hydrogen bioreactors. Mitchell S. Felder, M.D., the CEO and Chairman of the Board of NanoLogix, Inc. stated "The recent extensive innovations created by the NanoLogix scientists should greatly help us in obtaining a successful partnership with multinational energy concerns with whom we are negotiating. We believe that hydrogen holds the key to completely changing the worldwide energy paradigm, and for enabling America to achieve complete energy independence."
About NanoLogix, Inc.
NanoLogix is a nanobiotechnology company whose extensive portfolio of patents have application and marketability in the following areas: nanoscale microfluidics for the rapid identification of disease causing pathogens utilizing BioMEMS; production of high value hydrogen from agricultural feedstock, industrial waste water and municipal waste streams; nontoxic induction of apoptosis (a method for inducing a genetically based induction of "cell suicide") in cancer cells utilizing hydrophobic hydrocarbons; and the bio-remediation of air, water and soils of harmful contaminants.
Forward-Looking Statements
This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
FOR FURTHER INFORMATION, go to the Company's website at: http://NanoLogix.net
NanoLogix, Inc.CONTACT: NanoLogix, Inc., +1-724-346-1302
Web site: http://NanoLogix.net/
